Clinlogix Expands Safety Services
Clinlogix
, a clinical research organization located just outside Philadelphia, is taking steps to broaden the services they provide. In recent years, pharmaceutical, biotech, and medical device companies have begun to outsource portions, or all, of their clinical trials. With this recent trend, clinical research organizations have grown in importance as they help complete these clinical trials.
On October 1, 2012, Julie McCusker joined Clinlogix to kick-off their Safety Services.
“I am excited to be part of company with such integrity,” said Julie McCusker. “Product safety needs to get back to its roots of exceptional data quality, with the combination of people, process and technology. Clinlogix is poised to deliver high-quality, on time and on budget. Safety services for devices, products and drugs are quickly changing in the safety arena. From case processing through aggregate reporting and one-off safety projects, Clinlogix’s experienced project team, is client focused and delivers results.”
JeanMarie Markham, President and CEO of Clinlogix, stressed the importance of the new service saying, “As outsourcing continues to be the norm, and the proliferation of small biopharmaceutical and medical device companies continues, it is becoming increasingly imperative for companies to have a strategic partner that can provide a web-based safety management platform via a proven, validated technology such as Oracle Argus to successfully meet regulatory compliance, at an affordable price point. It is not sufficient, though to have the technology; it must be coupled with a highly skilled and proficient safety team to maximize the effectiveness of the program.”
Clinlogix uses Oracle Argus supported by Sentrx, the industry leaders in pharmacovigilance solutions. The safety system, coupled with our new Senior Director, Safety Services, will allow the company to compete in a new fiel
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
